The Newsroom
Find out the latest about Calidi. Announcements, press coverage, publications, and company info—it’s all here.
Press Release
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
Press Release
event
NeuroNova
Supernova
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
May 14, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
May 1, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
April 19, 2024
Discover More
Discover More
Discover More
Publication
event
NeuroNova & SuperNova
NeuroNova
Supernova
Stem Cell Platforms for Enhanced Oncolytic Virotherapy
April 16, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
April 16, 2024
Discover More
Discover More
Discover More
Publication
event
NeuroNova & SuperNova
NeuroNova
Supernova
Deciphering Anticancer Mechanisms of Oncolytic Virus-loaded Stem Cells
April 9, 2024
Discover More
Discover More
Discover More
Press Release
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
May 14, 2024
Discover More
Press Release
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
May 1, 2024
Discover More
Press Release
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
April 19, 2024
Discover More
Press Release
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
April 16, 2024
Discover More
Press Release
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024
April 9, 2024
Discover More
Press Release
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
March 15, 2024
Discover More
Publication
event
SuperNova (SNV)
NeuroNova
Supernova
Abstract 6542: CAL1 vaccinia virus as oncolytic agent and potential use of cell-based platform to enhance its therapeutic effects
August 15, 2020
Discover More
Discover More
Publication
event
SuperNova (SNV)
NeuroNova
Supernova
Enhancement of the therapeutic effects of oncolytic vaccinia virus by using autologous and allogeneic cell-based delivery platforms.
May 25, 2020
Discover More
Discover More
Publication
event
NeuroNova (NNV)
NeuroNova
Supernova
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
May 18, 2020
Discover More
Discover More
Publication
event
NeuroNova (NNV)
NeuroNova
Supernova
ASCO-SITC Clinical Immuno-Oncology Symposium February 6-8, 2020 Orlando, Florida.
February 6, 2020
Discover More
Discover More
Publication
event
SuperNova (SNV)
NeuroNova
Supernova
A cell-based platform to potentiate oncolytic virus: Potential approach for cancer therapies.
February 4, 2020
Discover More
Discover More
Publication
event
NeuroNova (NNV)
NeuroNova
Supernova
First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells
August 19, 2019
Discover More
Discover More
Media
Scientific Advisory Board Member Interview - Ashok Srivastava, MD/PH.D.
February 3, 2024
Discover More
Media
Scientific Advisory Board Member Interview - W.K. Alfred Yung, MD
February 3, 2024
Discover More
Media
Scientific Advisory Board Member Interview - Bernard Fox, PhD,
February 3, 2024
Discover More
Media
Scientific Advisory Board Member Interview - Santosh Kesari, MD/PH.D.
February 3, 2024
Discover More
Media
Big Biz TV - Allan Camaisa
December 4, 2023
Discover More
Media
Big Biz TV - Stephen Thesing
December 4, 2023
Discover More
In The News
Calidi Biotherapeutics: A Promising Player in the Cancer Treatment Market
October 9, 2023
Discover More
Discover More
In The News
Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player
October 9, 2023
Discover More
Discover More